News
Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...
Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...
GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.
Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...
What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...
Guidelines for pregnancy care in individuals with preexisting diabetes mellitus include stopping GLP-1 RA use and avoiding metformin.
For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.
Lupin has received USFDA approval for generic diabetes medications, specifically Liraglutide Injection and Glucagon for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results